Dybul Mark 4
4 · Enochian Biosciences Inc · Filed Sep 27, 2018
Insider Transaction Report
Form 4
Dybul Mark
Director
Transactions
- Award
Option to Purchase Common Stock
2018-09-19$5.74/sh+5,226$29,997→ 12,834 totalExercise: $5.74From: 2019-02-28Exp: 2028-09-19→ Common Stock (5,226 underlying)
Footnotes (1)
- [F1]On September 19, 2018, Dr. Dybul was granted an option to purchase shares of common stock of Enochian Biosciences, Inc. valued at $30,000, said option to vest on the anniversary date of Dr. Dybul's appointment as director of Enochian, exercisable at the closing market price per share on the date of the grant.